BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20398276)

  • 1. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
    BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma, but not interferon-alpha, induces SOCS 3 expression in human melanoma cell lines.
    Kovarik A; Fojtova M; Boudny V; Adamkova L; Lauerova L; Kovarik J
    Melanoma Res; 2005 Dec; 15(6):481-8. PubMed ID: 16314732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
    Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
    J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
    Song MM; Shuai K
    J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
    Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
    Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
    J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
    Fojtova M; Boudny V; Kovarik A; Lauerova L; Adamkova L; Souckova K; Jarkovsky J; Kovarik J
    Br J Cancer; 2007 Jul; 97(2):231-7. PubMed ID: 17579625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.
    Xu Y; Wang W; Gou A; Li H; Tian Y; Yao M; Yang R
    Mol Med Rep; 2015 Jan; 11(1):583-8. PubMed ID: 25322862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α.
    Tomita S; Ishibashi K; Hashimoto K; Sugino T; Yanagida T; Kushida N; Shishido K; Aikawa K; Sato Y; Suzutani T; Yamaguchi O
    Cancer Sci; 2011 Jan; 102(1):57-63. PubMed ID: 21054677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
    Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
    Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
    Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
    Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SOCS1 knockdown sensitize anti-tumor activity of IFN-alpha2a-NGR].
    Huang QC; Lei XY; Liu Y; Sui WJ; Li S; Zhang YQ; Yan Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):412-5. PubMed ID: 20423643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
    Zheng J; Yang P; Tang Y; Pan Z; Zhao D
    J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
    Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
    J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.